Terumo Corporation
Terumo Corporation TRUMY Peers
See (TRUMY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TRUMY | $15.97 | -2.20% | 23.5B | 30.11 | $0.53 | +0.66% |
| SRTOY | $21.85 | -1.67% | 212.5B | 87.38 | $0.25 | +0.35% |
| ESLOY | $142.43 | +0.25% | 131.2B | 47.59 | $2.99 | +1.58% |
| ESLOF | $282.86 | -2.10% | 130.8B | 46.59 | $6.07 | +1.57% |
| MECNY | $88.63 | +0.00% | 107.8B | N/A | N/A | N/A |
| SOAGY | $45.17 | -3.95% | 71.6B | 140.19 | $0.32 | +0.19% |
| HOCPF | $127.11 | +2.67% | 43.2B | 31.86 | $3.99 | +0.85% |
| HOCPY | $122.68 | -1.46% | 42B | 31.15 | $3.93 | +0.42% |
| RSMDF | $23.42 | -7.10% | 29.3B | 26.31 | $0.89 | +0.79% |
| TRUMF | $17.88 | +11.19% | 27.3B | 34.22 | $0.54 | +0.96% |
Stock Comparison
TRUMY vs SRTOY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SRTOY has a market cap of 212.5B. Regarding current trading prices, TRUMY is priced at $15.97, while SRTOY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SRTOY's P/E ratio is 87.38. In terms of profitability, TRUMY's ROE is +0.09%, compared to SRTOY's ROE of +0.05%. Regarding short-term risk, TRUMY is less volatile compared to SRTOY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ESLOY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, ESLOY has a market cap of 131.2B. Regarding current trading prices, TRUMY is priced at $15.97, while ESLOY trades at $142.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas ESLOY's P/E ratio is 47.59. In terms of profitability, TRUMY's ROE is +0.09%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ESLOF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, ESLOF has a market cap of 130.8B. Regarding current trading prices, TRUMY is priced at $15.97, while ESLOF trades at $282.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas ESLOF's P/E ratio is 46.59. In terms of profitability, TRUMY's ROE is +0.09%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs MECNY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, MECNY has a market cap of 107.8B. Regarding current trading prices, TRUMY is priced at $15.97, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas MECNY's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to MECNY's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SOAGY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SOAGY has a market cap of 71.6B. Regarding current trading prices, TRUMY is priced at $15.97, while SOAGY trades at $45.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SOAGY's P/E ratio is 140.19. In terms of profitability, TRUMY's ROE is +0.09%, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, TRUMY is less volatile compared to SOAGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs HOCPF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, HOCPF has a market cap of 43.2B. Regarding current trading prices, TRUMY is priced at $15.97, while HOCPF trades at $127.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas HOCPF's P/E ratio is 31.86. In terms of profitability, TRUMY's ROE is +0.09%, compared to HOCPF's ROE of +0.21%. Regarding short-term risk, TRUMY is more volatile compared to HOCPF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs HOCPY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, HOCPY has a market cap of 42B. Regarding current trading prices, TRUMY is priced at $15.97, while HOCPY trades at $122.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas HOCPY's P/E ratio is 31.15. In terms of profitability, TRUMY's ROE is +0.09%, compared to HOCPY's ROE of +0.20%. Regarding short-term risk, TRUMY is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs RSMDF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, RSMDF has a market cap of 29.3B. Regarding current trading prices, TRUMY is priced at $15.97, while RSMDF trades at $23.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas RSMDF's P/E ratio is 26.31. In terms of profitability, TRUMY's ROE is +0.09%, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, TRUMY is more volatile compared to RSMDF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TRUMF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, TRUMF has a market cap of 27.3B. Regarding current trading prices, TRUMY is priced at $15.97, while TRUMF trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas TRUMF's P/E ratio is 34.22. In terms of profitability, TRUMY's ROE is +0.09%, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, TRUMY is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CLPBF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, CLPBF has a market cap of 21.6B. Regarding current trading prices, TRUMY is priced at $15.97, while CLPBF trades at $95.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas CLPBF's P/E ratio is 30.25. In terms of profitability, TRUMY's ROE is +0.09%, compared to CLPBF's ROE of +0.27%. Regarding short-term risk, TRUMY is more volatile compared to CLPBF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CLPBY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, CLPBY has a market cap of 21.5B. Regarding current trading prices, TRUMY is priced at $15.97, while CLPBY trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas CLPBY's P/E ratio is 30.90. In terms of profitability, TRUMY's ROE is +0.09%, compared to CLPBY's ROE of +0.27%. Regarding short-term risk, TRUMY is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SAUHY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SAUHY has a market cap of 21.1B. Regarding current trading prices, TRUMY is priced at $15.97, while SAUHY trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SAUHY's P/E ratio is 36.75. In terms of profitability, TRUMY's ROE is +0.09%, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, TRUMY is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SAUHF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SAUHF has a market cap of 20.6B. Regarding current trading prices, TRUMY is priced at $15.97, while SAUHF trades at $129.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SAUHF's P/E ratio is 35.64. In terms of profitability, TRUMY's ROE is +0.09%, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, TRUMY is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SDMHF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SDMHF has a market cap of 20.5B. Regarding current trading prices, TRUMY is priced at $15.97, while SDMHF trades at $206.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SDMHF's P/E ratio is 86.34. In terms of profitability, TRUMY's ROE is +0.09%, compared to SDMHF's ROE of +0.05%. Regarding short-term risk, TRUMY is less volatile compared to SDMHF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SSSGY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SSSGY has a market cap of 15.4B. Regarding current trading prices, TRUMY is priced at $15.97, while SSSGY trades at $42.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SSSGY's P/E ratio is 132.84. In terms of profitability, TRUMY's ROE is +0.09%, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, TRUMY is less volatile compared to SSSGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SARTF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SARTF has a market cap of 15.3B. Regarding current trading prices, TRUMY is priced at $15.97, while SARTF trades at $200.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SARTF's P/E ratio is 125.12. In terms of profitability, TRUMY's ROE is +0.09%, compared to SARTF's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to SARTF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SUVPF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SUVPF has a market cap of 14.9B. Regarding current trading prices, TRUMY is priced at $15.97, while SUVPF trades at $259.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SUVPF's P/E ratio is 160.88. In terms of profitability, TRUMY's ROE is +0.09%, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to SUVPF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs FSPKF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, FSPKF has a market cap of 13B. Regarding current trading prices, TRUMY is priced at $15.97, while FSPKF trades at $22.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas FSPKF's P/E ratio is 58.16. In terms of profitability, TRUMY's ROE is +0.09%, compared to FSPKF's ROE of +0.28%. Regarding short-term risk, TRUMY is more volatile compared to FSPKF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OCPNF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, OCPNF has a market cap of 12.9B. Regarding current trading prices, TRUMY is priced at $15.97, while OCPNF trades at $11.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas OCPNF's P/E ratio is 16.59. In terms of profitability, TRUMY's ROE is +0.09%, compared to OCPNF's ROE of +0.16%. Regarding short-term risk, TRUMY is more volatile compared to OCPNF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SSMXY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SSMXY has a market cap of 10.1B. Regarding current trading prices, TRUMY is priced at $15.97, while SSMXY trades at $16.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SSMXY's P/E ratio is 27.90. In terms of profitability, TRUMY's ROE is +0.09%, compared to SSMXY's ROE of +0.12%. Regarding short-term risk, TRUMY is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SSMXF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SSMXF has a market cap of 9.5B. Regarding current trading prices, TRUMY is priced at $15.97, while SSMXF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SSMXF's P/E ratio is 26.38. In terms of profitability, TRUMY's ROE is +0.09%, compared to SSMXF's ROE of +0.12%. Regarding short-term risk, TRUMY is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs YPHDF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, YPHDF has a market cap of 7.3B. Regarding current trading prices, TRUMY is priced at $15.97, while YPHDF trades at $535.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas YPHDF's P/E ratio is 67.14. In terms of profitability, TRUMY's ROE is +0.09%, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, TRUMY is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CNVVF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, CNVVF has a market cap of 7.1B. Regarding current trading prices, TRUMY is priced at $15.97, while CNVVF trades at $3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas CNVVF's P/E ratio is 38.64. In terms of profitability, TRUMY's ROE is +0.09%, compared to CNVVF's ROE of +0.16%. Regarding short-term risk, TRUMY is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CNVVY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, CNVVY has a market cap of 6.9B. Regarding current trading prices, TRUMY is priced at $15.97, while CNVVY trades at $13.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas CNVVY's P/E ratio is 36.24. In terms of profitability, TRUMY's ROE is +0.09%, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, TRUMY is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs FLMNY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, FLMNY has a market cap of 5.6B. Regarding current trading prices, TRUMY is priced at $15.97, while FLMNY trades at $13.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas FLMNY's P/E ratio is 29.78. In terms of profitability, TRUMY's ROE is +0.09%, compared to FLMNY's ROE of +0.17%. Regarding short-term risk, TRUMY is less volatile compared to FLMNY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs FLMNF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, FLMNF has a market cap of 5.4B. Regarding current trading prices, TRUMY is priced at $15.97, while FLMNF trades at $64.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas FLMNF's P/E ratio is 28.19. In terms of profitability, TRUMY's ROE is +0.09%, compared to FLMNF's ROE of +0.17%. Regarding short-term risk, TRUMY is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CZMWF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, CZMWF has a market cap of 5.2B. Regarding current trading prices, TRUMY is priced at $15.97, while CZMWF trades at $59.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas CZMWF's P/E ratio is 28.83. In terms of profitability, TRUMY's ROE is +0.09%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to CZMWF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CZMWY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, CZMWY has a market cap of 5.2B. Regarding current trading prices, TRUMY is priced at $15.97, while CZMWY trades at $59.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas CZMWY's P/E ratio is 28.82. In terms of profitability, TRUMY's ROE is +0.09%, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ADDLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, TRUMY is priced at $15.97, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, TRUMY's ROE is +0.09%, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs AHICF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, AHICF has a market cap of 4.4B. Regarding current trading prices, TRUMY is priced at $15.97, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas AHICF's P/E ratio is 59.89. In terms of profitability, TRUMY's ROE is +0.09%, compared to AHICF's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to AHICF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SHWGF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SHWGF has a market cap of 3.4B. Regarding current trading prices, TRUMY is priced at $15.97, while SHWGF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SHWGF's P/E ratio is 12.67. In terms of profitability, TRUMY's ROE is +0.09%, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, TRUMY is more volatile compared to SHWGF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ANSLY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, ANSLY has a market cap of 2.9B. Regarding current trading prices, TRUMY is priced at $15.97, while ANSLY trades at $79.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas ANSLY's P/E ratio is 24.38. In terms of profitability, TRUMY's ROE is +0.09%, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, TRUMY is less volatile compared to ANSLY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TCHBF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, TCHBF has a market cap of 2.7B. Regarding current trading prices, TRUMY is priced at $15.97, while TCHBF trades at $211.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas TCHBF's P/E ratio is 32.06. In terms of profitability, TRUMY's ROE is +0.09%, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to TCHBF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ANSLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, ANSLF has a market cap of 2.6B. Regarding current trading prices, TRUMY is priced at $15.97, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, TRUMY's ROE is +0.09%, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, TRUMY is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TCGGY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, TCGGY has a market cap of 2.3B. Regarding current trading prices, TRUMY is priced at $15.97, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas TCGGY's P/E ratio is 27.27. In terms of profitability, TRUMY's ROE is +0.09%, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, TRUMY is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BOEUF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, BOEUF has a market cap of 2.1B. Regarding current trading prices, TRUMY is priced at $15.97, while BOEUF trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas BOEUF's P/E ratio is 141.30. In terms of profitability, TRUMY's ROE is +0.09%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, TRUMY is less volatile compared to BOEUF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs GRRMF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, GRRMF has a market cap of 2B. Regarding current trading prices, TRUMY is priced at $15.97, while GRRMF trades at $56.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas GRRMF's P/E ratio is 26.64. In terms of profitability, TRUMY's ROE is +0.09%, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to GRRMF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs EKTAY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, EKTAY has a market cap of 1.9B. Regarding current trading prices, TRUMY is priced at $15.97, while EKTAY trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas EKTAY's P/E ratio is 82.50. In terms of profitability, TRUMY's ROE is +0.09%, compared to EKTAY's ROE of +0.02%. Regarding short-term risk, TRUMY is less volatile compared to EKTAY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs EKTAF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, EKTAF has a market cap of 1.8B. Regarding current trading prices, TRUMY is priced at $15.97, while EKTAF trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas EKTAF's P/E ratio is 83.67. In terms of profitability, TRUMY's ROE is +0.09%, compared to EKTAF's ROE of +0.02%. Regarding short-term risk, TRUMY is more volatile compared to EKTAF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs NPRRF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, NPRRF has a market cap of 1.5B. Regarding current trading prices, TRUMY is priced at $15.97, while NPRRF trades at $8.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas NPRRF's P/E ratio is 43.32. In terms of profitability, TRUMY's ROE is +0.09%, compared to NPRRF's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to NPRRF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TGLVY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, TGLVY has a market cap of 1.3B. Regarding current trading prices, TRUMY is priced at $15.97, while TGLVY trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas TGLVY's P/E ratio is 66.82. In terms of profitability, TRUMY's ROE is +0.09%, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, TRUMY is less volatile compared to TGLVY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TDVXF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, TDVXF has a market cap of 1.3B. Regarding current trading prices, TRUMY is priced at $15.97, while TDVXF trades at $12.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas TDVXF's P/E ratio is 82.87. In terms of profitability, TRUMY's ROE is +0.09%, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, TRUMY is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BITGF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, TRUMY is priced at $15.97, while BITGF trades at $15.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas BITGF's P/E ratio is 45.50. In terms of profitability, TRUMY's ROE is +0.09%, compared to BITGF's ROE of +0.06%. Regarding short-term risk, TRUMY is less volatile compared to BITGF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs PBHDF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, PBHDF has a market cap of 1.1B. Regarding current trading prices, TRUMY is priced at $15.97, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, TRUMY's ROE is +0.09%, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SHWGY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SHWGY has a market cap of 918.6M. Regarding current trading prices, TRUMY is priced at $15.97, while SHWGY trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SHWGY's P/E ratio is 13.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, TRUMY is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs NNCSF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, NNCSF has a market cap of 773.5M. Regarding current trading prices, TRUMY is priced at $15.97, while NNCSF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas NNCSF's P/E ratio is 84.92. In terms of profitability, TRUMY's ROE is +0.09%, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, TRUMY is more volatile compared to NNCSF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs KSRBF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, KSRBF has a market cap of 686.6M. Regarding current trading prices, TRUMY is priced at $15.97, while KSRBF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas KSRBF's P/E ratio is 3.86. In terms of profitability, TRUMY's ROE is +0.09%, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, TRUMY is more volatile compared to KSRBF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SAFLY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SAFLY has a market cap of 537.2M. Regarding current trading prices, TRUMY is priced at $15.97, while SAFLY trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SAFLY's P/E ratio is 17.62. In terms of profitability, TRUMY's ROE is +0.09%, compared to SAFLY's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to SAFLY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs JNDOF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, TRUMY is priced at $15.97, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, TRUMY's ROE is +0.09%, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, TRUMY is less volatile compared to JNDOF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs HGYMF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, HGYMF has a market cap of 524.8M. Regarding current trading prices, TRUMY is priced at $15.97, while HGYMF trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas HGYMF's P/E ratio is 33.81. In terms of profitability, TRUMY's ROE is +0.09%, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, TRUMY is more volatile compared to HGYMF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SAFLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SAFLF has a market cap of 520.2M. Regarding current trading prices, TRUMY is priced at $15.97, while SAFLF trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SAFLF's P/E ratio is 21.50. In terms of profitability, TRUMY's ROE is +0.09%, compared to SAFLF's ROE of +0.05%. Regarding short-term risk, TRUMY is less volatile compared to SAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SPMXF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, TRUMY is priced at $15.97, while SPMXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, TRUMY is less volatile compared to SPMXF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CLHLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, CLHLF has a market cap of 365.5M. Regarding current trading prices, TRUMY is priced at $15.97, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, TRUMY's ROE is +0.09%, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, TRUMY is more volatile compared to CLHLF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs GUERF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, TRUMY is priced at $15.97, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas GUERF's P/E ratio is 8.19. In terms of profitability, TRUMY's ROE is +0.09%, compared to GUERF's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TSNLF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, TSNLF has a market cap of 252.4M. Regarding current trading prices, TRUMY is priced at $15.97, while TSNLF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas TSNLF's P/E ratio is 33.06. In terms of profitability, TRUMY's ROE is +0.09%, compared to TSNLF's ROE of +0.21%. Regarding short-term risk, TRUMY is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OPSSF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, TRUMY is priced at $15.97, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, TRUMY's ROE is +0.09%, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, TRUMY is less volatile compared to OPSSF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs EEOIF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, TRUMY is priced at $15.97, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, TRUMY's ROE is +0.09%, compared to EEOIF's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs UEEC Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, UEEC has a market cap of 26.2M. Regarding current trading prices, TRUMY is priced at $15.97, while UEEC trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas UEEC's P/E ratio is -10.20. In terms of profitability, TRUMY's ROE is +0.09%, compared to UEEC's ROE of +1.31%. Regarding short-term risk, TRUMY is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs GVDI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, GVDI has a market cap of 15.8M. Regarding current trading prices, TRUMY is priced at $15.97, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas GVDI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs YBGJ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, YBGJ has a market cap of 15.6M. Regarding current trading prices, TRUMY is priced at $15.97, while YBGJ trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas YBGJ's P/E ratio is -6.49. In terms of profitability, TRUMY's ROE is +0.09%, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, TRUMY is less volatile compared to YBGJ. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OTCFF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, OTCFF has a market cap of 14M. Regarding current trading prices, TRUMY is priced at $15.97, while OTCFF trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas OTCFF's P/E ratio is -15.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to OTCFF's ROE of -7.85%. Regarding short-term risk, TRUMY is more volatile compared to OTCFF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs IMTH Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, IMTH has a market cap of 8.1M. Regarding current trading prices, TRUMY is priced at $15.97, while IMTH trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas IMTH's P/E ratio is -0.41. In terms of profitability, TRUMY's ROE is +0.09%, compared to IMTH's ROE of +2.29%. Regarding short-term risk, TRUMY is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TEVNF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, TEVNF has a market cap of 7.6M. Regarding current trading prices, TRUMY is priced at $15.97, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas TEVNF's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, TRUMY is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs RSCF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, RSCF has a market cap of 6.7M. Regarding current trading prices, TRUMY is priced at $15.97, while RSCF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas RSCF's P/E ratio is -7.80. In terms of profitability, TRUMY's ROE is +0.09%, compared to RSCF's ROE of +0.08%. Regarding short-term risk, TRUMY is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs TUTH Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, TUTH has a market cap of 6.3M. Regarding current trading prices, TRUMY is priced at $15.97, while TUTH trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas TUTH's P/E ratio is -2.64. In terms of profitability, TRUMY's ROE is +0.09%, compared to TUTH's ROE of +0.31%. Regarding short-term risk, TRUMY is less volatile compared to TUTH. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BLMHF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, TRUMY is priced at $15.97, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, TRUMY's ROE is +0.09%, compared to BLMHF's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs PXMVF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, TRUMY is priced at $15.97, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, TRUMY's ROE is +0.09%, compared to PXMVF's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ECIA Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, ECIA has a market cap of 4.4M. Regarding current trading prices, TRUMY is priced at $15.97, while ECIA trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas ECIA's P/E ratio is -18.50. In terms of profitability, TRUMY's ROE is +0.09%, compared to ECIA's ROE of -0.33%. Regarding short-term risk, TRUMY is less volatile compared to ECIA. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs MCDA Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, MCDA has a market cap of 4.2M. Regarding current trading prices, TRUMY is priced at $15.97, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas MCDA's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to MCDA's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to MCDA. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CBSC Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, CBSC has a market cap of 4.2M. Regarding current trading prices, TRUMY is priced at $15.97, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas CBSC's P/E ratio is -3.70. In terms of profitability, TRUMY's ROE is +0.09%, compared to CBSC's ROE of +1.21%. Regarding short-term risk, TRUMY is less volatile compared to CBSC. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs NSTGQ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, TRUMY is priced at $15.97, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, TRUMY is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OJSY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, OJSY has a market cap of 454.3K. Regarding current trading prices, TRUMY is priced at $15.97, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas OJSY's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to OJSY's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to OJSY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs PDMI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, TRUMY is priced at $15.97, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas PDMI's P/E ratio is -0.01. In terms of profitability, TRUMY's ROE is +0.09%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, TRUMY is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs REMI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, REMI has a market cap of 200K. Regarding current trading prices, TRUMY is priced at $15.97, while REMI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas REMI's P/E ratio is -1.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to REMI's ROE of -0.08%. Regarding short-term risk, TRUMY is more volatile compared to REMI. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs WHSI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, TRUMY is priced at $15.97, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas WHSI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, TRUMY is less volatile compared to WHSI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BLFE Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, TRUMY is priced at $15.97, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas BLFE's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to BLFE's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to BLFE. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs QTXB Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, TRUMY is priced at $15.97, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas QTXB's P/E ratio is -0.05. In terms of profitability, TRUMY's ROE is +0.09%, compared to QTXB's ROE of +0.00%. Regarding short-term risk, TRUMY is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs CEOS Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, CEOS has a market cap of 110.3K. Regarding current trading prices, TRUMY is priced at $15.97, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas CEOS's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to CEOS's ROE of +1.18%. Regarding short-term risk, TRUMY is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SDCCQ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SDCCQ has a market cap of 40.3K. Regarding current trading prices, TRUMY is priced at $15.97, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, TRUMY is more volatile compared to SDCCQ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs GMVDF Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, TRUMY is priced at $15.97, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas GMVDF's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, TRUMY is more volatile compared to GMVDF. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ASFX Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, ASFX has a market cap of 17.5K. Regarding current trading prices, TRUMY is priced at $15.97, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas ASFX's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, TRUMY is more volatile compared to ASFX. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs INND Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, INND has a market cap of 17.2K. Regarding current trading prices, TRUMY is priced at $15.97, while INND trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas INND's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to INND's ROE of +0.32%. Regarding short-term risk, TRUMY is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs MDIT Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, MDIT has a market cap of 8.6K. Regarding current trading prices, TRUMY is priced at $15.97, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas MDIT's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, TRUMY is more volatile compared to MDIT. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs LANZ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, LANZ has a market cap of 4.2K. Regarding current trading prices, TRUMY is priced at $15.97, while LANZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas LANZ's P/E ratio is 0.15. In terms of profitability, TRUMY's ROE is +0.09%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, TRUMY is less volatile compared to LANZ. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs DGEN Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, TRUMY is priced at $15.97, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas DGEN's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, TRUMY is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SVSO Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SVSO has a market cap of 2.6K. Regarding current trading prices, TRUMY is priced at $15.97, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SVSO's P/E ratio is -0.01. In terms of profitability, TRUMY's ROE is +0.09%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, TRUMY is more volatile compared to SVSO. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs LFPI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, LFPI has a market cap of 2K. Regarding current trading prices, TRUMY is priced at $15.97, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas LFPI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, TRUMY is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SEYE Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, TRUMY is priced at $15.97, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SEYE's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to SEYE's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs BGMD Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, TRUMY is priced at $15.97, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas BGMD's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to BGMD's ROE of +0.00%. Regarding short-term risk, TRUMY is more volatile compared to BGMD. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs ADLI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, TRUMY is priced at $15.97, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas ADLI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, TRUMY is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs VSMD Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, VSMD has a market cap of 801. Regarding current trading prices, TRUMY is priced at $15.97, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas VSMD's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, TRUMY is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs HRAL Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, HRAL has a market cap of 396. Regarding current trading prices, TRUMY is priced at $15.97, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas HRAL's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to HRAL's ROE of +0.13%. Regarding short-term risk, TRUMY is more volatile compared to HRAL. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs MICRD Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, MICRD has a market cap of 317. Regarding current trading prices, TRUMY is priced at $15.97, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas MICRD's P/E ratio is -0.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, TRUMY is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs RGBOQ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, TRUMY is priced at $15.97, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs SECI Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, SECI has a market cap of 31. Regarding current trading prices, TRUMY is priced at $15.97, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas SECI's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to SECI's ROE of -0.00%. Regarding short-term risk, TRUMY is more volatile compared to SECI. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs VTEQ Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, TRUMY is priced at $15.97, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, TRUMY's ROE is +0.09%, compared to VTEQ's ROE of N/A. Regarding short-term risk, TRUMY is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.
TRUMY vs OCPNY Comparison
TRUMY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TRUMY stands at 23.5B. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, TRUMY is priced at $15.97, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TRUMY currently has a P/E ratio of 30.11, whereas OCPNY's P/E ratio is N/A. In terms of profitability, TRUMY's ROE is +0.09%, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, TRUMY is more volatile compared to OCPNY. This indicates potentially higher risk in terms of short-term price fluctuations for TRUMY.